Tereza Dvořáková

Statistics

Publications

Citations

191

H-Index

Active since

2019

Affiliations

Walloon Excellence in Lifesciences and Biotechnology(Current)

de Duve Institute

Ludwig Cancer Research

Tereza Dvořáková is an author at Walloon Excellence in Lifesciences and Biotechnology specializing in oncology, tumor microenvironment, and hypoxia adaptation.

ORCID

Publications per year

2019–2024

Publications

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression

Veronica Finisguerra, Tereza Dvořáková, Matteo Formenti et al. · Journal for ImmunoTherapy of Cancer · 2023 · 111 citations · Full text

Medicine, Immunology, Oncology +17

Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers

Delia Hoffmann, Tereza Dvořáková, Vincent Stroobant et al. · Cancer Immunology Research · 2019 · 57 citations · Full text

Medicine, Cancer Biology, Oncology +13

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Tereza Dvořáková, Veronica Finisguerra, Matteo Formenti et al. · Nature Communications · 2024 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance

Delia Hoffmann, Tereza Dvořáková, Florence Schramme et al. · Frontiers in Immunology · 2020 · 10 citations · Full text

Life Sciences, Immunology, Pharmacology +17

1–4 of 4